Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
Dev IT gains on securing Rs 4-cr orders from Alivus Lifesciences     Back
(02 Jul 2025)
According to an exchange filing, the engagement includes a major order worth Rs 3.60 crore for Microsoft Select Plus perpetual licenses. While the licenses will be billed directly by the Licensing Solution Partner, DEVIT played a key advisory role in aligning Alivus Lifesciences’ IT infrastructure with the appropriate Microsoft licensing model. This highlights DEVIT’s capability in managing complex enterprise IT requirements and supporting clients in their digital transformation journeys.

In addition, DEVIT secured a direct order worth Rs 80 lakh from Alivus Lifesciences for a suite of enterprise software solutions. This includes products from Microsoft, Zoho, Adobe, and TeamViewer, underscoring the company’s ability to deliver integrated, multi-product IT solutions tailored to specific business needs.

The company said these developments further enhance DEVIT’s positioning as a trusted technology partner, particularly in high-growth sectors such as pharmaceuticals. DEVIT continues to focus on enabling digital modernization through scalable solutions and a customer-centric approach.

Pranav Pandya founder & chairman of Dev Information Technology said, “This milestone reflects not just a business win, but the trust our clients place in our team’s ability to solve real-world challenges with the right technology. I’m proud of the effort and commitment shown by Yogesh, Julie, Sanjay, Himani, and Paritosh in driving this forward, and grateful for the steady support from Jaimin and Vishal behind the scenes.

We’re also seeing meaningful traction in the government sector, which adds further depth to our portfolio. It’s encouraging to see how our work is creating impact—whether in boardrooms or for public service platforms. As we move ahead, we remain focused on building lasting relationships and delivering solutions that not only meet immediate needs but support long-term growth for our clients.”

Dev Information Technology (DEV IT) is a technology solution provider helping companies in their digital transformation from advisory to execution, backed by expert applications and infrastructure management.

The company's consolidated net profit fell 70.5% to Rs 1.22 crore on a 18.7% rise in revenue from operations to Rs 51.55 crore in Q4 FY25 over Q4 FY24.

Top